Kanamori K, Ross B D
Magnetic Resonance Spectroscopy Laboratory, Huntington Medical Research Institutes, Pasadena, CA 91105.
Biochem J. 1993 Jul 15;293 ( Pt 2)(Pt 2):461-8. doi: 10.1042/bj2930461.
The rate of glutamine synthesis and utilization at steady state was measured in vivo in the brains of hyperammonaemic rats by 15N n.m.r. in combination with biochemical techniques. Rats were given an intravenous 15NH4+ infusion at the rate of 4.8 +/- 0.3 mmol/h per kg body wt. for 3.5 +/- 0.2 h, followed by 14NH4+ infusion at the same rate for an additional 5.1 h (chase period). During the chase period, blood ammonia (0.61 +/- 0.015 mumol/g), brain ammonia (2.9 +/- 0.3 mumol/g), glutamate (9.4 +/- 0.8 mumol/g) and glutamine (15N + 14N; 14.4 +/- 1.3 mumol/g) were at steady state. The rate of change in the cerebral [5-15N]glutamine concentration was measured in vivo by 15N n.m.r. at 20.27 MHz. To estimate 15N enrichment of precursor ammonia for glutamine synthetase (GS) in astrocytes which are interposed between cerebral capillaries and neurons, 15N enrichments of blood and brain ammonia were measured by gas chromatography-mass spectrometry. The in vivo rate of glutamine synthesis, which is equal to the rate of glutamine utilization at steady state, was estimated, from the observed rate of change in [5-15N]glutamine concentration and 15N enrichment of brain glutamine, to be 4.8 +/- 1.1 mumol/h per g of brain if 15N enrichment of ammonia at the site of GS in astrocytes is equal to that of blood-borne ammonia, and 13.0 +/- 3.9 mumol/h per g if it is equal to that measured for the whole brain. The observed GS activity in vivo in the brain of the hyperammonaemic rat is 2-5% of the reported optimum activity in vitro measured at enzyme-saturating concentrations of all substrates. The result suggests that substrates and/or cofactors other than ammonia kinetically limit GS activity in vivo. The g.c. chromatogram and mass spectrum of ammonia-derived N-trifluoroacetyl-dibutylglutamate (TAB-glutamate) are shown in Supplementary Publication SUP 50170 (4 pages), which has been deposited at the British Library Document Supply Centre, Boston Spa, Wetherby, West Yorkshire, U.K., from whom copies can be obtained on the terms indicated in Biochem. J.
采用¹⁵N核磁共振结合生化技术,在体内测定了高氨血症大鼠大脑中谷氨酰胺在稳态时的合成和利用速率。以4.8±0.3 mmol/h per kg体重的速率给大鼠静脉输注¹⁵NH₄⁺ 3.5±0.2 h,随后以相同速率输注¹⁴NH₄⁺ 5.1 h(追踪期)。在追踪期内,血氨(0.61±0.015 μmol/g)、脑氨(2.9±0.3 μmol/g)、谷氨酸(9.4±0.8 μmol/g)和谷氨酰胺(¹⁵N + ¹⁴N;14.4±1.3 μmol/g)处于稳态。通过20.27 MHz的¹⁵N核磁共振在体内测量大脑中[5-¹⁵N]谷氨酰胺浓度的变化率。为了估计介于脑毛细血管和神经元之间的星形胶质细胞中谷氨酰胺合成酶(GS)的前体氨的¹⁵N丰度,通过气相色谱 - 质谱法测量血氨和脑氨的¹⁵N丰度。根据观察到的[5-¹⁵N]谷氨酰胺浓度变化率和脑谷氨酰胺的¹⁵N丰度,估计体内谷氨酰胺合成速率(等于稳态时谷氨酰胺利用速率):如果星形胶质细胞中GS位点的氨的¹⁵N丰度等于血源性氨的¹⁵N丰度,则为4.8±1.1 μmol/h per g脑;如果等于全脑测量值,则为13.0±3.9 μmol/h per g脑。在高氨血症大鼠大脑中观察到的体内GS活性是在所有底物酶饱和浓度下体外报道的最佳活性的2 - 5%。结果表明,除氨之外的底物和/或辅因子在动力学上限制了体内GS活性。氨衍生的N - 三氟乙酰 - 二丁基谷氨酸(TAB - 谷氨酸)的气相色谱图和质谱图见补充出版物SUP 50170(4页),该出版物已存放在英国西约克郡韦瑟比波士顿温泉的大英图书馆文献供应中心,可按《生物化学杂志》所示条件从该中心获取复印件。